AI Summary & Key Takeaways
AI InsightIn those with a problematic buying behavior, any mood disorder should be examined.
📌 3 Key Takeaways
Özet
The aim of this study was to screen for the comorbidity of compulsive buying disorder with psychiatric disorders and associated sociodemographic variables. One hundred and ninety-six volunteering psychiatric patients attending Üsküdar University Outpatient Psychiatry Clinic formed the study sample. Compulsive buying disorder (CBD) was screened with Compulsive Buying Scale (CBS). CBD was found among 17 people (8.67%) in this sample of 196 patients (female n= 127, 67.4%; male n=69, 32.6%). Psychiatric diagnosis of patients with CBD were as follows: major depressive disorder (n=3,1.5%),cyclothymic disorder (n=2,1%), mood disorder not otherwise specified (NOS) (n=2, 1%), bipolar disorder (n=2, 1%), anxiety disorder NOS (n=2, 1%), obsessive compulsive disorder (n=2,1%), substance dependence (n=1, 0.5%), Tourette disorder (n=1, 0.5%) and generalized anxiety disorder (n=1,0.5%). In this cross-sectional screening study there seems to be a remarkable comorbidity of CBD and mood disorders. CBD may not be an independent entity but a symptom of mood disorders. In all patients with a mood disorder buying behavior should be evaluated routinely. In those with a problematic buying behavior, any mood disorder should be examined.